drug
as of 2026-07-01Chlorpromazine
Chlorpromazine Hydrochloride
MeSH D002746
at a glance
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
SchizophreniaControl Manifestations of the Manic Type of Mani-depressive IllnessTreatment of SchizophreniaPorphyria, Acute IntermittentControl Nausea and VomitingBipolar DisorderAdjunct in the Treatment of TetanusSchizophreniaAcute Intermittent PorphyriaAnti-PsychoticRelief of Intractable HiccupsManiaBipolar DisorderPsychotic DisordersVomitingRelief of Restlessness and Apprehension Before Surgery
Trials
5
Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)
NCT02600741—Completed
Assessment of Intra-subject Variability in the Bioavailability of Chlorpromazine Hydrochloride
NCT02943213Phase 1Completed
Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features
NCT00202293Phase 4Completed
Efficacy and Safety of Quetiapine Fumarate in the Treatment of Schizophrenic Patients
NCT00882518Phase 3Completed
Clozapine Versus Chlorpromazine for Treatment-Unresponsive Schizophrenia
NCT00169039Phase 4Terminated
KOLs & investigators
5
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
indication
indication
indication
KOL
Alan I. Green, MD
personKOL score 5
Michael Castiglione
personKOL score —
Niufan Gu, MD
personKOL score —
Dr. Yolandi Swart, FCPHM(SA)
personKOL score —